Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Clinical trial NCT05931393 · RECRUITING
Trial details
- NCT number
- NCT05931393
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.